Investors
Mach7 Technologies (ASX: M7T) provides enterprise imaging software that helps healthcare organizations manage, access and share diagnostic imaging data across complex environments. The Mach7 platform includes a Vendor Neutral Archive (VNA), the eUnity Enterprise Diagnostic Viewer and an expanding suite of Flamingo modules, extending capabilities across workflow, interoperability and data management to support a more complete view of the patient record. Together, these capabilities help healthcare organizations build a unified, longitudinal patient record that integrates diagnostic imaging with broader clinical data.
Designed for interoperability and scale, Mach7 is increasingly aligned with leading cloud ecosystems such as Amazon Web Services (AWS) and Oracle Cloud Infrastructure (OCI), helping customers modernize imaging infrastructure and prepare for AI-enabled clinical workflows. Mach7 serves healthcare organizations worldwide, including integrated delivery networks, national health systems and specialist imaging providers.
Share Price
Investor Events
View all resources
FY26 Q4 Results Investor Webinar
Teri Thomas (CEO), Shawni Hadfield (interim CFO) and Francoise Dixon (Investor Relations) present Mach7’s Q4 FY26 results in this recorded webinar.
FY26 Q3 Results Investor Webinar
Teri Thomas (CEO), Dan Lee (CFO), Todd Stallard (EVP Sales and Marketing) and Francoise Dixon (Investor Relations) present Mach7’s Q3 FY26 results.
FY26 First Half Results Investor Webinar
Teri Thomas (CEO), Dan Lee (CFO) and Francoise Dixon (Investor Relations) present Mach7’s first-half FY26 results in this recorded webinar.
FY26 Q2 Results Investor Webinar
Teri Thomas (CEO), Dan Lee (CFO) and Francoise Dixon (Investor Relations) present Mach7’s Q2 FY26 financial results in this recorded webinar.
FY26 Q1 Results Investor Webinar
Teri Thomas (CEO), Dan Lee (CFO) and Francoise Dixon (Investor Relations) present Mach7’s Q1 FY26 financial results in this recorded webinar.
FY25 Annual Report to the Shareholders
Mach7’s Annual Report to its Shareholders for Fiscal Year 2025 (FY25) has been released.
Investor Information
Share Registry Corporate Governance Right to Receive Documents


